![]() | Up a level |
Loibl, Sibylle, Jackisch, Christian, Seiler, Sabine, Rastogi, Priya, Huober, Lens, Denkert, Carsten, Schneeweiss, Andreas, Hanusch, Claus, Fasching, Peter A., Blohmer, Jens-Uwe, Untch, Michael, Rhiem, Kerstin, Solbach, Christine, Nekljudova, Valentina, Costantino, Joseph, Wolmark, Norman and Geyer, Charles (2020). A Randomized, Double-Blind, Phase III Trial of Neoadjuvant Chemotherapy (NACT) with atezolizumab/Placebo in Patients with Triple-Negative Breast Cancer (TNBC) Followed by Adjuvant Continuation of atezolizumab/Placebo (Gepardouze). Oncol. Res. Treat., 43. S. 24 - 26. BASEL: KARGER. ISSN 2296-5262
Tutt, Andrew N. J., Garber, Judy E., Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro ORCID: 0000-0001-9501-4509, Fielding, Anitra, Balmana, Judith, Domchek, Susan M., Gelmon, Karen A., Hollingsworth, Simon J., Korde, Larissa A., Linderholm, Barbro, Bandos, Hanna, Senkus, E., Suga, Jennifer M., Shao, Z., Pippas, Andrew W., Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A., Lucas, Peter C., Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita, Steger, Guenther G., Costantino, Joseph P., Arahmani, Amal, Wolmark, Norman, McFadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R., Yothers, Greg
ORCID: 0000-0002-7965-7333, Campbell, Christine and Geyer, Charles E.
(2021).
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N. Engl. J. Med., 384 (25).
S. 2394 - 2406.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406